Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Viveve Medical Inc    VIVE

VIVEVE MEDICAL INC (VIVE)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 12/14 06:42:08 pm
1.425 USD   -1.72%
05/07VIVEVE MEDICAL INC : quaterly earnings release
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/10/2018 12/11/2018 12/12/2018 12/13/2018 12/14/2018 Date
1.345(c) 1.42(c) 1.47(c) 1.45(c) 1.42 Last
607 131 378 236 313 234 110 262 58 292 Volume
-0.37% +5.58% +3.52% -1.36% -2.07% Change
More quotes
Financials (USD)
Sales 2018 18,2 M
EBIT 2018 -42,5 M
Net income 2018 -46,7 M
Debt 2018 -
Yield 2018 -
Sales 2019 22,4 M
EBIT 2019 -39,3 M
Net income 2019 -43,3 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 3,58x
Capi. / Sales2019 2,91x
Capitalization 65,0 M
More Financials
Company
Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three... 
More about the company
Surperformance© ratings of Viveve Medical Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VIVEVE MEDICAL INC
12/12VIVEVE MEDICAL : Announces Closing of Public Offering of Shares of Common Stock
AQ
12/11VIVEVE MEDICAL : Announces Closing of Public Offering of Shares of Common Stock
AQ
12/10VIVEVE MEDICAL, INC. : Entry into a Material Definitive Agreement, Other Events,..
AQ
12/07VIVEVE MEDICAL : Announces Proposed Public Offering of Shares of Common Stock
AQ
12/07Viveve Announces Pricing of Public Offering of Shares of Common Stock
GL
12/06VIVEVE MEDICAL, INC. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
12/06Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feas..
GL
12/06Viveve Announces Proposed Public Offering of Shares of Common Stock
GL
12/04VIVEVE MEDICAL, INC. : Entry into a Material Definitive Agreement, Change in Dir..
AQ
11/29Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion L..
GL
More news
Analyst Recommendations on VIVEVE MEDICAL INC
More recommendations
Sector news : Advanced Medical Equipment & Technology - NEC
12/13DANAHER : Initiates 2019 Earnings Guidance
DJ
11/29Former Nissan executive Kelly denies financial misconduct allegations - lawye..
RE
11/29FORMER NISSAN EXECUTIVE KELLY DENIES : lawyer
RE
11/28Knorr Bremse forecasts higher 2018 sales in first results since IPO
RE
11/28Auditor had questioned Nissan on payments to Ghosn at heart of scandal
RE
More sector news : Advanced Medical Equipment & Technology - NEC
Chart VIVEVE MEDICAL INC
Duration : Period :
Viveve Medical Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIVEVE MEDICAL INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 5,17 $
Spread / Average Target 256%
EPS Revisions
Managers
NameTitle
Scott C. Durbin Chief Executive Officer & Director
James G. Atkinson President & Chief Business Officer
Dan S. Janney Chairman
Marty Kerber Vice President-Operations
Jim B. Robbins Chief Financial & Accounting Officer
Sector and Competitors
1st jan.Capitalization (M$)
VIVEVE MEDICAL INC-70.82%65
THERMO FISHER SCIENTIFIC27.20%97 230
DANAHER CORPORATION10.43%71 843
INTUITIVE SURGICAL40.37%58 499
BOSTON SCIENTIFIC CORPORATION49.66%51 173
ILLUMINA53.15%49 189